Skip to main navigation

Investor Relations

October 13, 2020

Abivax secures EUR 15m non-dilutive financing from Kreos Capital

September 30, 2020

ABIVAX ANNOUNCES THE RELEASE OF ITS 2020 HALF-YEAR FINANCIAL REPORT

September 24, 2020

ABIVAX presents first-half 2020 financial results and operations update

September 02, 2020

Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study

July 02, 2020

Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial